NCT05677776

Brief Summary

It is aimed to examine the retrospective features of covid-19 patients followed in our hospital with pneumothorax.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2022

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

1.4 years

First QC Date

January 7, 2023

Last Update Submit

February 3, 2023

Conditions

COVID-19Pneumothorax

Keywords

COVID-19pneumothorax

Outcome Measures

Primary Outcomes (1)

  • relationship between covid-19 and pneumothorax

    Inflammatory markers, C-reactive protein (CRP), lactate dehydrogenase (LDH), ferritin, D-dimer, procalcitonin, blood gas lactate, creatine kinase, white blood cells, baseline laboratory test results including WBC, lymphocyte, neutrophil counts, platelets, urea, creatinine, and neutrophil/lymphocyte ratio were documented for each patient. Respiratory support status, the fraction of inspired oxygen (FiO2), positive end-expiratory pressure (PEEP) values, tidal volume, and duration of the mechanical ventilator (MV) stay were determined.

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

over 18 years , PCR testin positive COVID-19 patients

You may qualify if:

  • over 18 years
  • covid-19 patient
  • having a diagnosis of pneumothorax
  • PCR test positive and lung tomography pneumonic involvement

You may not qualify if:

  • PCR test negative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hulya TOPCU

Çorum, 19030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Pneumothorax

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPleural Diseases

Study Officials

  • Hilal BOYACI

    ÇorumTRH

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 7, 2023

First Posted

January 10, 2023

Study Start

July 1, 2021

Primary Completion

December 10, 2022

Study Completion

December 30, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Locations

TU(1)